Titan Pharmaceuticals Inc (OTCQB:TTNP.PK)

0.702
Delayed Data
As of Apr 20
 +0.012 / +1.74%
Today’s Change
0.44
Today|||52-Week Range
0.87
+51.95%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 1
2014
Quarter 2
2014
Quarter 3
2014
Quarter 4
2014
Revenue and IncomeNet Revenues911.0K911.0K911.0K912.0K
 
 
 
 
 
Depreciation And Amortization88.0K88.0K89.0K88.0K
 
 
 
 
 
 
Operating ExpensesGross Income------824.0K
 
 
General Expenses1.8M1.4M1.6M2.1M
 
 
 
 
 
Research And Development949.0K748.0K782.0K1.6M
 
 
 
 
 
Total Operating Expenses1.8M1.5M1.6M2.2M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-934.0K-550.0K-738.0K-1.3M
 
 
 
 
 
Extraordinary Credit0.000.001.5M770.0K
 
 
 
Extraordinary Charge-864.0K-284.0K0.000.00
 
 
 
Other Expenses-6.0K-8.0K-7.0K10.0K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-1.8M-842.0K716.0K-473.0K
 
 
 
 
 
Net Income-1.8M-842.0K716.0K-473.0K
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS88.9M89.0M89.0M108.2M
 
 
 
 
 
Shares To Calculate EPS Diluted88.9M89.0M89.4M108.4M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.02-$0.01-$0.01-$0.01
 
 
 
 
 
EPS Diluted-$0.02-$0.01-$0.01-$0.01
 
 
 
 
 
 

To view my watchlist

Not a member yet?

Sign up now for a free account